Correlation Between Mineralys Therapeutics, and Aileron Therapeutics

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Aileron Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Aileron Therapeutics.

Diversification Opportunities for Mineralys Therapeutics, and Aileron Therapeutics

0.68

Correlation Coefficient

Mineralys Therapeutics,  Aileron Therapeutics

Poor diversification

The 3 months correlation between Mineralys and Aileron is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Aileron Therapeutics go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Aileron Therapeutics

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Aileron Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Mineralys Therapeutics, Common is 1.71 times less risky than Aileron Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The Aileron Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  235.00  in Aileron Therapeutics on October 5, 2024 and sell it today you would lose (10.00) from holding Aileron Therapeutics or give up 4.26% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Aileron Therapeutics

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Mineralys Therapeutics, is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Aileron Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aileron Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Mineralys Therapeutics, and Aileron Therapeutics

The main advantage of trading using opposite Mineralys Therapeutics, and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.

The idea behind Mineralys Therapeutics, Common and Aileron Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.